FR16C0003I1 - - Google Patents

Info

Publication number
FR16C0003I1
FR16C0003I1 FR16C0003C FR16C0003I1 FR 16C0003 I1 FR16C0003 I1 FR 16C0003I1 FR 16C0003 C FR16C0003 C FR 16C0003C FR 16C0003 I1 FR16C0003 I1 FR 16C0003I1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23519346&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR16C0003(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of FR16C0003I1 publication Critical patent/FR16C0003I1/fr
Application granted granted Critical
Publication of FR16C0003I2 publication Critical patent/FR16C0003I2/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • C07C69/618—Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety having unsaturation outside the six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR16C0003C 1995-02-07 2016-02-03 Triglycerides et esters ethyliques d'acides phenylalcanoiques et phenylalcenoiques utiles dans le traitement de differents troubles Active FR16C0003I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38493595A 1995-02-07 1995-02-07
PCT/US1996/000940 WO1996024571A1 (en) 1995-02-07 1996-02-06 Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic acid useful in treatment of various disorders

Publications (2)

Publication Number Publication Date
FR16C0003I1 true FR16C0003I1 (cg-RX-API-DMAC7.html) 2016-03-25
FR16C0003I2 FR16C0003I2 (fr) 2016-06-24

Family

ID=23519346

Family Applications (1)

Application Number Title Priority Date Filing Date
FR16C0003C Active FR16C0003I2 (fr) 1995-02-07 2016-02-03 Triglycerides et esters ethyliques d'acides phenylalcanoiques et phenylalcenoiques utiles dans le traitement de differents troubles

Country Status (9)

Country Link
US (3) US5968979A (cg-RX-API-DMAC7.html)
EP (1) EP0858441B1 (cg-RX-API-DMAC7.html)
AT (1) ATE201013T1 (cg-RX-API-DMAC7.html)
AU (1) AU4858796A (cg-RX-API-DMAC7.html)
CA (1) CA2212047C (cg-RX-API-DMAC7.html)
DE (1) DE69612755T2 (cg-RX-API-DMAC7.html)
ES (1) ES2157422T3 (cg-RX-API-DMAC7.html)
FR (1) FR16C0003I2 (cg-RX-API-DMAC7.html)
WO (1) WO1996024571A1 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642543B1 (en) 2000-09-26 2003-11-04 The Board Of Trustees Of The Leland Stanford Junior University Thin and thick gate oxide transistors on a functional block of a CMOS circuit residing within the core of an IC chip
US7842727B2 (en) 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) * 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7312247B2 (en) * 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US20030195255A1 (en) * 2002-04-12 2003-10-16 Summar Marshall L. Method for treating hepatic encephalopathies
US20040229948A1 (en) * 2002-04-12 2004-11-18 Summar Marshall L. Method for preventing hepatic encephalopathic episodes
EP1511477A4 (en) 2002-05-22 2008-04-09 Errant Gene Therapeutics Llc HISTONE DEACETYLASE INHIBITORS BASED ON ALPHA-KETO-EPOXYDE COMPOUNDS
JP2006508986A (ja) * 2002-11-20 2006-03-16 エルラント ゲネ セラペウチクス エルエルシー ヒストンデアセチラーゼ阻害剤による肺細胞の治療方法
US20090260743A1 (en) * 2003-11-21 2009-10-22 William David Mawby Tire manufacturing method for improving the uniformity of a tire
CA2587013A1 (en) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
WO2009134460A1 (en) * 2008-04-29 2009-11-05 Hyperion Therapeutics Methods of treatment using ammonia-scavenging drugs
JP5577341B2 (ja) * 2008-08-29 2014-08-20 ハイペリオン セラピューティクス, インコーポレイテッド アンモニア捕捉薬を使用する処置方法
EP3263102A1 (en) 2011-09-30 2018-01-03 Horizon Therapeutics, LLC Methods of therapeutic monitoring of nitrogen scavenging drugs
BR112014026138A2 (pt) 2012-04-20 2017-06-27 Hyperion Therapeutics Inc métodos de monitoramento terapêutico de pró-fármacos de ácido fenilacético
HUE036133T2 (hu) * 2012-11-21 2018-06-28 Horizon Therapeutics Llc Eljárások hepatikus enkefalopátia kezelésére szolgáló nitrogénelvonó gyógyszerek beadására és értékelésére
PL2986325T3 (pl) 2013-10-14 2020-03-31 Immedica Pharma Ab Sposoby leczenia zaburzenia cyklu mocznikowego
IN2013MU03442A (cg-RX-API-DMAC7.html) 2013-10-30 2015-07-17 Lupin Ltd
JP2017501972A (ja) 2013-11-14 2017-01-19 ウルトラジェニクス ファーマシューティカル インク.Ultragenyx Pharmaceutical Inc. トリグリセリドの固体組成物及びその使用
EP3137116B1 (en) 2014-04-30 2020-12-16 The Johns Hopkins University Dendrimer compositions and their use in treatment of diseases of the eye
EP3180031A1 (en) 2014-08-13 2017-06-21 The Johns Hopkins University Selective dendrimer delivery to brain tumors
CN108430514B (zh) 2015-10-29 2023-11-03 约翰霍普金斯大学 用于治疗过氧化物酶体病症和脑白质营养不良的组合物和方法
US9914692B2 (en) 2016-05-25 2018-03-13 Horizon Therapeutics, Llc Procedure for the preparation of 4-phenyl butyrate and uses thereof
US10668040B2 (en) 2017-09-11 2020-06-02 Horizon Therapeutics, Llc Treatment of urea cycle disorders in neonates and infants
WO2021113662A2 (en) 2019-12-04 2021-06-10 Ashvattha Therapeutics, Inc. Dendrimer compositions and methods for drug delivery to the eye

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders

Also Published As

Publication number Publication date
EP0858441B1 (en) 2001-05-09
WO1996024571A1 (en) 1996-08-15
US6060510A (en) 2000-05-09
EP0858441A4 (cg-RX-API-DMAC7.html) 1998-08-19
CA2212047C (en) 2010-11-16
US6083984A (en) 2000-07-04
FR16C0003I2 (fr) 2016-06-24
AU4858796A (en) 1996-08-27
CA2212047A1 (en) 1996-08-15
EP0858441A1 (en) 1998-08-19
ES2157422T3 (es) 2001-08-16
DE69612755D1 (de) 2001-06-13
DE69612755T2 (de) 2001-08-23
US5968979A (en) 1999-10-19
ATE201013T1 (de) 2001-05-15

Similar Documents

Publication Publication Date Title
BR122012014331A2 (cg-RX-API-DMAC7.html)
BRPI9612258B1 (cg-RX-API-DMAC7.html)
BRPI9612138B1 (cg-RX-API-DMAC7.html)
IN186223B (cg-RX-API-DMAC7.html)
IN186492B (cg-RX-API-DMAC7.html)
CH0741373H1 (cg-RX-API-DMAC7.html)
FR2729512B1 (cg-RX-API-DMAC7.html)
EP0850063A4 (cg-RX-API-DMAC7.html)
IN183659B (cg-RX-API-DMAC7.html)
BR7501503U (cg-RX-API-DMAC7.html)
IN188200B (cg-RX-API-DMAC7.html)
IN188145B (cg-RX-API-DMAC7.html)
IN185103B (cg-RX-API-DMAC7.html)
IN183449B (cg-RX-API-DMAC7.html)
BR7502120U (cg-RX-API-DMAC7.html)
IN184681B (cg-RX-API-DMAC7.html)
IN182238B (cg-RX-API-DMAC7.html)
IN183402B (cg-RX-API-DMAC7.html)
CN3031742S (cg-RX-API-DMAC7.html)
CN3031655S (cg-RX-API-DMAC7.html)
CN3032332S (cg-RX-API-DMAC7.html)
CN3031001S (cg-RX-API-DMAC7.html)
CN3033225S (cg-RX-API-DMAC7.html)
CN3034473S (cg-RX-API-DMAC7.html)
CN3030760S (cg-RX-API-DMAC7.html)